Certified by Founder Lodge
HealthCap
Sweden - Stockholm, Stockholm
INVESTOR
1 Disclosed Funding Rounds $135,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
HealthCap is a family of venture capital funds investing globally in life sciences. With more than EUR 1.2 billion raised since the start in 1996, HealthCap is one of the largest specialized
| Company | Date | Round | Raised |
|---|---|---|---|
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Rampart Bioscience |
October, 25 ,2023 | Series A | $85,000,000 |
 Aro Biotherapeutics |
November, 29 ,2023 | Series B | $41,500,000 |
 SynOx Therapeutics |
April, 23 ,2024 | Series B | $75,000,000 |
 Tribune Therapeutics |
March, 27 ,2025 | Seed | $39,883,965 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
